Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
57,417,494
-
Total 13F shares
-
50,974,067
-
Share change
-
+539,235
-
Total reported value
-
$2,808,311,303
-
Put/Call ratio
-
121%
-
Price per share
-
$55.10
-
Number of holders
-
235
-
Value change
-
+$33,778,388
-
Number of buys
-
139
-
Number of sells
-
78
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) as of Q4 2022
As of 31 Dec 2022,
Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) was held by
235 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,974,067 shares.
The largest 10 holders included
Valor Management LLC, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Vivo Capital, LLC, Invesco Ltd., JANUS HENDERSON GROUP PLC, venBio Partners LLC, STATE STREET CORP, and MACQUARIE GROUP LTD.
This page lists
237
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.